Top Clinical Trials companies in South Korea by Free Cash Flow Yield
South Korea
# |
Name |
Free Cash Flow Yield |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
|---|---|---|---|---|---|---|---|
| 1 |
-2.60% |
Jan. 14, 2025 | USD 17.25 | 0.74% |
|
South Korea |
|
| 2 |
-2.68% |
Jan. 14, 2025 | USD 21.07 | 1.40% |
|
South Korea |
|
| 3 |
-12.47% |
Jan. 14, 2025 | USD 10.57 | -0.48% |
|
South Korea |
|
| 4 |
-16.17% |
Jan. 14, 2025 | USD 1.67 | -1.86% |
|
South Korea |
|
| 5 |
-20.36% |
Jan. 14, 2025 | USD 3.10 | -1.75% |
|
South Korea |
|
| 6 |
-21.68% |
Jan. 14, 2025 | USD 3.70 | 0.18% |
|
South Korea |
|
| 7 |
-54.09% |
Jan. 14, 2025 | USD 1.17 | -3.48% |
|
South Korea |
Frequently Asked Questions
-
Which Clinical Trials company in South Korea has the highest Free Cash Flow Yield ?
The Clinical Trials company in South Korea with the highest Free Cash Flow Yield is Oscotec Inc. (KOSDAQ: 039200.KQ) at -2.60%.
-
Which Clinical Trials company in South Korea has the lowest Free Cash Flow Yield ?
The Clinical Trials company in South Korea with the lowest Free Cash Flow Yield is Gencurix Inc. (KOSDAQ: 229000.KQ) at -54.09%.
-
What are the top 10 Clinical Trials companies in South Korea by Free Cash Flow Yield ?
The top 10 Clinical Trials companies in South Korea by Free Cash Flow Yield are Oscotec Inc., ABL Bio Inc., OliX Pharmaceuticals,Inc, GeneOne Life Science, Inc., MedPacto, Inc., Genexine, Inc. and Gencurix Inc..
-
What are the bottom 10 Clinical Trials companies in South Korea by Free Cash Flow Yield ?
The bottom 10 Clinical Trials companies in South Korea by Free Cash Flow Yield are Gencurix Inc., Genexine, Inc., MedPacto, Inc., GeneOne Life Science, Inc., OliX Pharmaceuticals,Inc, ABL Bio Inc. and Oscotec Inc..